Long-term potentiation |
13 |
6.84E-22 |
33 |
ErbB signaling pathway |
12 |
1.16E-15 |
35 |
Dilated cardiomyopathy |
13 |
5.34E-14 |
36 |
ABC transporters |
8 |
5.27E-12 |
20 |
Prostate cancer |
13 |
2.15E-11 |
33 |
Glutamatergic synapse |
13 |
1.71E-10 |
40 |
Neurotrophin signaling pathway |
13 |
3.43E-10 |
42 |
Regulation of actin cytoskeleton |
14 |
3.90E-10 |
65 |
Arrhythmogenic right ventricular cardiomyopathy [ARVC] |
13 |
5.59E-10 |
31 |
Focal adhesion |
14 |
3.69E-09 |
60 |
Hypertrophic cardiomyopathy [HCM] |
12 |
5.80E-09 |
30 |
Axon guidance |
13 |
9.22E-09 |
46 |
Ubiquitin mediated proteolysis |
12 |
1.07E-08 |
45 |
Glioma |
13 |
1.69E-08 |
27 |
Insulin signaling pathway |
14 |
1.69E-08 |
43 |
Endometrial cancer |
12 |
4.55E-07 |
20 |
B cell receptor signaling pathway |
11 |
5.96E-07 |
26 |
Non-small cell lung cancer |
12 |
7.85E-07 |
20 |
PI3K-Akt signaling pathway |
14 |
1.36E-06 |
86 |
GnRH signaling pathway |
12 |
1.80E-06 |
29 |
Progesterone-mediated oocyte maturation |
12 |
1.80E-06 |
28 |
mTOR signaling pathway |
12 |
2.29E-06 |
22 |
Endocytosis |
12 |
2.84E-06 |
56 |
Acute myeloid leukemia |
10 |
3.72E-06 |
20 |
Pancreatic cancer |
13 |
4.62E-06 |
24 |
Amyotrophic lateral sclerosis |
8 |
5.70E-06 |
18 |
Phosphatidylinositol signaling system |
12 |
9.39E-06 |
29 |
Fc gamma R-mediated phagocytosis |
12 |
1.80E-05 |
29 |
Calcium signaling pathway |
12 |
1.87E-05 |
50 |
Bacterial invasion of epithelial cells |
11 |
1.89E-05 |
24 |
Endocrine and other factor-regulated calcium reabsorption |
7 |
1.97E-05 |
18 |
Dopaminergic synapse |
14 |
1.97E-05 |
39 |
Small cell lung cancer |
14 |
4.85E-05 |
26 |
TGF-beta signaling pathway |
13 |
5.27E-05 |
25 |
Shigellosis |
11 |
5.54E-05 |
21 |
Cholinergic synapse |
14 |
6.70E-05 |
36 |
Gap junction |
10 |
7.56E-05 |
26 |
Chronic myeloid leukemia |
12 |
7.56E-05 |
24 |
Melanoma |
11 |
7.66E-05 |
23 |
HIF-1 signaling pathway |
14 |
7.66E-05 |
32 |
Colorectal cancer |
11 |
7.84E-05 |
21 |
Long-term depression |
11 |
0.00010297 |
22 |
Type II diabetes mellitus |
8 |
0.000254913 |
16 |
MAPK signaling pathway |
13 |
0.000254913 |
67 |
Oocyte meiosis |
12 |
0.00028102 |
36 |
Gastric acid secretion |
12 |
0.00028102 |
23 |
Inositol phosphate metabolism |
10 |
0.000438238 |
20 |
Natural killer cell mediated cytotoxicity |
12 |
0.000438238 |
39 |
Vascular smooth muscle contraction |
13 |
0.00054281 |
34 |
Aldosterone-regulated sodium reabsorption |
10 |
0.000675186 |
13 |
Pathways in cancer |
15 |
0.000805191 |
88 |
Melanogenesis |
12 |
0.001443074 |
27 |
RNA degradation |
10 |
0.001527123 |
21 |
Taurine and hypotaurine metabolism |
4 |
0.002484891 |
4 |
Renal cell carcinoma |
11 |
0.002484891 |
22 |
Retrograde endocannabinoid signaling |
13 |
0.002555835 |
32 |
T cell receptor signaling pathway |
11 |
0.002611728 |
29 |
VEGF signaling pathway |
11 |
0.002830415 |
19 |
Glycosylphosphatidylinositol[GPI]-anchor biosynthesis |
6 |
0.003458651 |
9 |
Serotonergic synapse |
11 |
0.004099713 |
30 |
Amphetamine addiction |
11 |
0.004449922 |
23 |
Propanoate metabolism |
7 |
0.005323316 |
10 |
GABAergic synapse |
12 |
0.005836946 |
28 |
Protein processing in endoplasmic reticulum |
14 |
0.00600624 |
43 |
Wnt signaling pathway |
14 |
0.006229163 |
42 |
Cell cycle |
12 |
0.006354843 |
33 |
Chemokine signaling pathway |
14 |
0.006702432 |
45 |
Glycerophospholipid metabolism |
12 |
0.008604037 |
26 |
Biotin metabolism |
1 |
0.01053896 |
1 |
Carbohydrate digestion and absorption |
9 |
0.01053896 |
12 |
Hepatitis B |
14 |
0.01246892 |
40 |
Circadian rhythm |
9 |
0.01363142 |
10 |
Osteoclast differentiation |
13 |
0.01363142 |
33 |
Tight junction |
13 |
0.01376918 |
35 |
Transcriptional misregulation in cancer |
14 |
0.0144959 |
46 |
mRNA surveillance pathway |
12 |
0.0145927 |
23 |
Adherens junction |
12 |
0.03073926 |
23 |
Viral myocarditis |
12 |
0.03463523 |
18 |
N-Glycan biosynthesis |
10 |
0.03514185 |
15 |
Salmonella infection |
12 |
0.04015256 |
21 |